ReviewJournal of clinical and translational science2020

Regulatory and strategic considerations for addressing immunogenicity and related responses in biopharmaceutical development programs.

Tyler C Vandivort et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.